Skip to content

Protective effect of sevoflurane on lung during necrotizing enterocolitis surgery: a randomized controlled trial

Protective effect of sevoflurane on lung during necrotizing enterocolitis surgery: a randomized controlled trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500107248
Enrollment
Unknown
Registered
2025-08-07
Start date
2025-09-01
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

necrotizing enterocolitis

Interventions

control group:Midazolam 2 mg/kg/h and remifentanil 0.25µg kg/min were infused
intervention group:Remifentanil 0.25µg kg/min was infused, and 1%-2% sevoflurane was inhaled continuously during the operation. The minimum alveolar effective concentration (MAC) was maintained at 1.0

Sponsors

Chongqing Health Center for Women and Children
Lead Sponsor

Eligibility

Sex/Gender
All
Age
0.1 Years to 0.3 Years

Inclusion criteria

Inclusion criteria: 1. Stage III NEC; 2. receiving general anesthesia; 3. NEC enterostomy was planned; 4. Admission to NICU after surgery

Exclusion criteria

Exclusion criteria: 1. allergy to narcotic drugs; 2. secondary surgery; 3. preoperative tracheal intubation >=24 hours; 4. It has been included in other clinical studies.

Design outcomes

Primary

MeasureTime frame
Inflammatory markers in postoperative bronchoalveolar lavage fluid;

Secondary

MeasureTime frame
Postoperative plasma inflammatory markers;oxygenation index;static compliance of lung;

Countries

China

Contacts

Public ContactXiaofeng Lei

Chongqing Health Center for Women and Children

3495926509@qq.com+86 131 1022 8169

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026